In vitro susceptibility of Capnocytophaga species to antimicrobial agents
Open Access
- 1 February 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (2) , 331-332
- https://doi.org/10.1128/aac.31.2.331
Abstract
A total of 33 clinical isolates of Capnocytophaga spp. were susceptible to 4-quinolone antimicrobial agents. The antipseudomonal penicillins tested were equally active against all isolates, as were cefuroxime, ceftriaxone, ceftizoxime, cefotaxime, latamoxef, and ceftazidime. Most isolates were resistant to trimethoprim, and some were resistant to aztreonam. Most regimens for the empirical treatment of septic episodes in immunocompromised patients are suitable for the treatment of Capnocytophaga spp. infections.This publication has 9 references indexed in Scilit:
- Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparisonJournal of Antimicrobial Chemotherapy, 1985
- Capnocytophaga ochracea: an unusual opportunistic pathogen.Journal of Clinical Pathology, 1985
- Capnocytophaga Species: Infections in Nonimmunocompromised and Immunocompromised HostsThe Journal of Infectious Diseases, 1985
- Capnocytophaga ochracea infection: two cases and a review of the published work.Journal of Clinical Pathology, 1984
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1981
- Antimicrobial susceptibility of CapnocytophagaAntimicrobial Agents and Chemotherapy, 1981
- CAPNOCYTOPHAGA SEPSIS: A NEWLY RECOGNISED CLINICAL ENTITY IN GRANULOCYTOPENIC PATIENTSThe Lancet, 1980
- Capnocytophaga: New genus of Gram-negative gliding bacteria. III. Physiological characterizationArchiv für Mikrobiologie, 1979